← Ishga qaytish
Ushbu ish iqtibos qilgan ishlar
72 ta ish
Ish: Neurological complications after covid-19 vaccination
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin +26
Maqola20208 iqtibosABIEfficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults
Lianpan Dai, Lidong Gao, Lifeng Tao +27
Maqola20227 iqtibosABIEfficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Lindsey R. Baden, Hana M. El Sahly, Brandon Essink +34
Maqola20206 iqtibosABINervous system involvement after infection with COVID-19 and other coronaviruses
Yeshun Wu, Xiaolin Xu, Zijun Chen +5
Sharh maqola20205 iqtibosABISafety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Jerald Sadoff, Glenda Gray, An Vandebosch +27
Maqola20214 iqtibosABIAn mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Lisa A. Jackson, Evan J. Anderson, Nadine Rouphael +30
Maqola20203 iqtibosABISafety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh, Robert W. Frenck, Ann R. Falsey +22
Maqola20203 iqtibosABISafety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
Tom T. Shimabukuro, Michael Nguyen, David Martin +1
Sharh maqola20153 iqtibosABIThe spectrum of post-vaccination inflammatory CNS demyelinating syndromes
Dimitrios Karussis, Panayiota Petrou
Sharh maqola20133 iqtibosABIImprovements in Gene Therapy
Thomas Ritter, Manfred Lehmann, Hans‐Dieter Volk
Sharh maqola20022 iqtibosABIIntravascular adenoviral agents in cancer patients: Lessons from clinical trials
Tony Reid, Robert S. Warren, David H. Kirn
Sharh maqola20022 iqtibosABIThe influence of innate and pre‐existing immunity on adenovirus therapy
Anne K. Zaiss, Hidevaldo B. Machado, Harvey R. Herschman
Sharh maqola20092 iqtibosABIEpilepsy and vaccinations: Italian guidelines
Dario Pruna, Paolo Balestri, Nelia Zamponi +8
Sharh maqola20132 iqtibosABIHemostasis factors and aging
Daniela Mari, Raffaella Coppola, Rita Provenzano
Sharh maqola20072 iqtibosABI